Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
Objectives. To determine how beta-amyloid 1-42 (Aβ 1-42), total tau (tTau), and phosphorylated tau (pTau) levels in CSF behave in a cohort of Thai patients from the Memory Clinic in Bangkok, Thailand. Methods. During 20092011, twenty eight subjects from the memory clinic at Siriraj Hospital had CSF...
Saved in:
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/13634 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.13634 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.136342018-06-11T12:21:11Z Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience V. Senanarong N. Siwasariyanon L. Washirutmangkur N. Poungvarin C. Ratanabunakit N. Aoonkaew S. Udomphanthurak Mahidol University Biochemistry, Genetics and Molecular Biology Medicine Neuroscience Objectives. To determine how beta-amyloid 1-42 (Aβ 1-42), total tau (tTau), and phosphorylated tau (pTau) levels in CSF behave in a cohort of Thai patients from the Memory Clinic in Bangkok, Thailand. Methods. During 20092011, twenty eight subjects from the memory clinic at Siriraj Hospital had CSF analysis for AD biomarkers. Aβ 1-42, tTau, and pTau (at amino acid 181) were measured in CSF by ELISA technique. Results. Mean of Thai mental state examination (TMSE) of 28 Thai cohort was 16.48 (6.63). Fourteen had AD, ten had non-AD dementia, and four non-cases were those with subjective memory complaint (SMC) without dementia. Mean CSF Aβ 1-42, tTau, ptau (181), and pTau/Aβ 1-42 in the AD group were 241.36 (60.14)pg/mL, 222.79 (212.24)pg/mL, 40.79 (27.84)pg/mL, and 0.18 (0.12) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-AD dementia group were 430.40 (125.18)pg/mL, 349.30 (692.16)pg/mL, 36.80 (14.90)pg/mL, and 0.09 (0.04) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-cases with SMC without dementia were 499.75 (93.44)pg/mL, 137.25 (62.74)pg/mL, 31.75 (17.48)pg/mL, and 0.06 (0.02). There is significant difference (P 0.05) among the 3 groups in CSF Aβ 1-42 and pTau/Aβ 1-42. We propose mean + 1.5 SD of CSF Aβ 1-42 in AD group (331.57pg/mL) to be the cut-off point in Thai subjects. Conclusion. There are significant different in CSF Aβ 1-42 and CSF p-tau/A 1-42 among those with AD, non-AD dementia and non cases with SMC without dementia in Thai cohort. Cut-off point of CSF Aβ 1-42 of 331.57pg/mL is suggested in Thai study. © 2012 V. Senanarong et al. 2018-06-11T04:34:28Z 2018-06-11T04:34:28Z 2012-08-17 Article International Journal of Alzheimer's Disease. (2012) 10.1155/2012/212063 20900252 2-s2.0-84864923986 https://repository.li.mahidol.ac.th/handle/123456789/13634 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84864923986&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Biochemistry, Genetics and Molecular Biology Medicine Neuroscience |
spellingShingle |
Biochemistry, Genetics and Molecular Biology Medicine Neuroscience V. Senanarong N. Siwasariyanon L. Washirutmangkur N. Poungvarin C. Ratanabunakit N. Aoonkaew S. Udomphanthurak Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience |
description |
Objectives. To determine how beta-amyloid 1-42 (Aβ 1-42), total tau (tTau), and phosphorylated tau (pTau) levels in CSF behave in a cohort of Thai patients from the Memory Clinic in Bangkok, Thailand. Methods. During 20092011, twenty eight subjects from the memory clinic at Siriraj Hospital had CSF analysis for AD biomarkers. Aβ 1-42, tTau, and pTau (at amino acid 181) were measured in CSF by ELISA technique. Results. Mean of Thai mental state examination (TMSE) of 28 Thai cohort was 16.48 (6.63). Fourteen had AD, ten had non-AD dementia, and four non-cases were those with subjective memory complaint (SMC) without dementia. Mean CSF Aβ 1-42, tTau, ptau (181), and pTau/Aβ 1-42 in the AD group were 241.36 (60.14)pg/mL, 222.79 (212.24)pg/mL, 40.79 (27.84)pg/mL, and 0.18 (0.12) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-AD dementia group were 430.40 (125.18)pg/mL, 349.30 (692.16)pg/mL, 36.80 (14.90)pg/mL, and 0.09 (0.04) accordingly. Mean CSF Aβ 1-42, tTau, pTau (181), and pTau/Aβ 1-42 in the non-cases with SMC without dementia were 499.75 (93.44)pg/mL, 137.25 (62.74)pg/mL, 31.75 (17.48)pg/mL, and 0.06 (0.02). There is significant difference (P 0.05) among the 3 groups in CSF Aβ 1-42 and pTau/Aβ 1-42. We propose mean + 1.5 SD of CSF Aβ 1-42 in AD group (331.57pg/mL) to be the cut-off point in Thai subjects. Conclusion. There are significant different in CSF Aβ 1-42 and CSF p-tau/A 1-42 among those with AD, non-AD dementia and non cases with SMC without dementia in Thai cohort. Cut-off point of CSF Aβ 1-42 of 331.57pg/mL is suggested in Thai study. © 2012 V. Senanarong et al. |
author2 |
Mahidol University |
author_facet |
Mahidol University V. Senanarong N. Siwasariyanon L. Washirutmangkur N. Poungvarin C. Ratanabunakit N. Aoonkaew S. Udomphanthurak |
format |
Article |
author |
V. Senanarong N. Siwasariyanon L. Washirutmangkur N. Poungvarin C. Ratanabunakit N. Aoonkaew S. Udomphanthurak |
author_sort |
V. Senanarong |
title |
Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience |
title_short |
Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience |
title_full |
Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience |
title_fullStr |
Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience |
title_full_unstemmed |
Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience |
title_sort |
alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: difference in cut-off levels from thai experience |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/13634 |
_version_ |
1763490188379553792 |